- Healthcare buyers increasingly price demand durability: whether patients keep coming after the deal closes, not just what the business earned before it.
- Transitions erode demand in predictable ways — rebrands, ownership and payer changes, key-provider attrition, and concentrated referral relationships.
- Brand capital can be scored: branded search demand, review velocity, GEO presence, referral concentration, and the ratio of organic to paid demand.
- It is built in the 12 to 18 months before an exit, not assembled in the data room. By diligence, the score is already set.
A healthcare platform comes to market with a clean number: trailing EBITDA, growing, defensible. A decade ago that number, and a multiple, was the conversation. Today the sharper buyers ask a second question before they price anything — will the patients still be here in eighteen months, or are we buying a demand curve that depends on the people and the brand we are about to change?
From earnings to durability
EBITDA is a record of what happened. It says nothing about whether the demand that produced it is loyal to the business or to the departing founder, the local brand, or a referral relationship that walks out the door at close. Buyers have learned this the expensive way, watching acquired practices quietly bleed volume in the year after a transition while the spreadsheet that justified the price assumed continuity. The shift is not unique to healthcare: by Ocean Tomo’s long-running study, intangible assets — brand, relationships, reputation — now make up roughly 90% of the market value of the S&P 500. In a business built on patient demand, that intangible is most of what a buyer is paying for.
So diligence has widened. Alongside quality of earnings, the careful buyer now runs a quality-of-demand analysis: how durable is the patient flow, and what happens to it when ownership, brand, and people change?
What erodes in transition
The leaks are predictable. A rebrand severs the name recognition patients searched for. An ownership change triggers reputational wobble in a community that valued independence. Payer or process changes interrupt the referral patterns that fed the funnel. And in clinician-led specialties, demand often belongs to a provider, not the platform — when they retire or leave, a share of the patient base follows or evaporates.
Each of these is foreseeable, which means each is underwritable. The buyer who maps them before close prices the risk. The one who assumes continuity inherits it.
Scoring brand capital
Brand capital sounds soft until you instrument it. Branded search demand — how many people seek this practice by name — is a direct read on equity that does not depend on ad spend. Review velocity and recency signal a living reputation rather than a banked one. GEO presence shows whether AI assistants will keep recommending the brand through the transition. Referral concentration exposes how much of the funnel rests on a handful of relationships. And the ratio of organic to paid demand reveals whether the business owns its patients or rents them.
None of these is exotic to measure. Together they turn “the brand is strong” into a score a buyer can defend in an investment committee.
Built before the data room
The uncomfortable truth for sellers: brand capital cannot be assembled during diligence. Branded demand, review history, and organic dependence are trailing signals that reflect what you built over years. By the time the bankers are engaged, the score is largely set.
Which makes this an operating priority, not a transaction one. The platforms that command a premium for demand durability started building it twelve to eighteen months before they went to market — and the ones that did not discovered, in the data room, that it was too late to fake.
The 1ness Take
Brand capital is migrating from the pitch deck to the balance sheet. Buyers are learning to price demand durability because they have been burned by assuming it, and the analytical tools to score it now exist. For sellers, that is either a discount or a premium, decided long before the first meeting.
The work to earn the premium is unglamorous and slow, which is exactly why it shows up in the multiple. You cannot buy it in the data room. You can only have built it.
Sources
- Ocean Tomo, “Intangible Asset Market Value Study” — intangibles now ~90% of S&P 500 market value.
